Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many people taking GLP-1 medications for weight loss wonder whether they can continue using hormonal birth control without concerns. The good news: clinical evidence shows no direct pharmacological interaction between GLP-1 agonists like semaglutide and oral contraceptives, intrauterine devices, or other hormonal methods. However, understanding how gastrointestinal side effects might affect medication absorption helps you make informed decisions about your health.
How GLP-1 Medications Work With Hormonal Contraceptives
GLP-1 receptor agonists function by mimicking the glucagon-like peptide-1 hormone, which signals fullness and slows stomach emptying. Hormonal birth control methods work through entirely different biological pathways—estrogen and progestin regulate the menstrual cycle and prevent ovulation at the brain and ovarian level. Because these medications target separate physiological systems, no metabolic conflict occurs between them.
The liver enzymes responsible for breaking down birth control hormones (primarily the cytochrome P450 system) are not significantly affected by semaglutide or tirzepatide. This means your contraceptive dose and efficacy remain stable when combining these treatments. Clinical studies of GLP-1 therapy in women of reproductive age have not identified contraceptive failure as a concern.
Gastrointestinal Side Effects and Oral Contraceptive Absorption
While GLP-1 medications and birth control don't interact chemically, the gastrointestinal effects of GLP-1 therapy warrant attention. Nausea, vomiting, and diarrhea—commonly reported during the initial weeks of treatment—could theoretically reduce how much oral contraceptive hormone your body absorbs from the pill. Severe or prolonged vomiting within 2 hours of taking an oral contraceptive is the primary absorption concern, though this scenario is uncommon during GLP-1 therapy.
Injectable semaglutide and tirzepatide carry a lower risk of acute gastrointestinal distress compared to oral formulations, as they bypass the stomach and enter the bloodstream directly. Women using injected GLP-1 compounds alongside oral birth control rarely experience absorption issues. If you choose an oral GLP-1 medication and experience significant nausea or vomiting, consult your healthcare provider about using a backup contraceptive method during that period.
Fertility, Pregnancy Planning, and GLP-1 Therapy
GLP-1 medications are not recommended during pregnancy because safety data in pregnant individuals remains limited. If you're planning to conceive, discuss discontinuing GLP-1 therapy with your healthcare provider beforehand. Once you stop taking semaglutide or tirzepatide, no residual effects prevent pregnancy—these medications leave your system within days of your last dose.
Women who become pregnant unexpectedly while on GLP-1 therapy should inform their physician immediately; stopping the medication is typically advised. Interestingly, some evidence suggests that weight loss achieved through GLP-1 therapy before conception may improve fertility outcomes in people with obesity-related ovulation problems, though individual results vary. Planning your transition off GLP-1 before attempting pregnancy ensures the safest approach.
PlexusDx Guidance: Combining GLP-1 and Birth Control Safely
PlexusDx recommends that patients using hormonal birth control discuss their contraceptive method during the initial consultation before starting semaglutide injection or other GLP-1 compounds. This conversation allows PlexusDx clinical staff to monitor for any gastrointestinal symptoms that might compromise absorption and to suggest alternatives if needed. Injectable options like PlexusDx Compounded Semaglutide Injection (starting at $149/month) present a lower absorption-risk profile than oral formulations.
Your PlexusDx provider can help you track any changes in your menstrual cycle or breakthrough bleeding—rare but possible signs that your body isn't absorbing enough contraceptive hormone—and recommend backup contraception or dose adjustments if necessary. The Precision Peptide Genetic Test (available as a $99 add-on after your first month of treatment) identifies your individual peptide-pathway predispositions, helping your provider optimize your GLP-1 protocol while accounting for your reproductive health needs.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Will semaglutide reduce how well my birth control pill works?
No direct interaction exists between semaglutide and oral contraceptives. However, if you experience severe vomiting early in your GLP-1 treatment, use backup contraception for that cycle. Most patients on PlexusDx Semaglutide Injection experience minimal gastrointestinal effects, so absorption concerns are rare.
Can I use an IUD or hormonal implant with GLP-1 therapy?
Yes, intrauterine devices and subdermal implants work independently of GLP-1 medications and carry no interaction risk. These methods bypass gastrointestinal absorption entirely, making them excellent choices for people prioritizing reliability while on weight-loss therapy.
What should I do if I become pregnant while taking GLP-1?
Contact your healthcare provider immediately to discontinue GLP-1 therapy. PlexusDx recommends stopping semaglutide or tirzepatide as soon as pregnancy is confirmed. The medication exits your system quickly, and no evidence suggests lasting harm to an early pregnancy.
Does GLP-1 therapy affect my menstrual cycle?
GLP-1 medications do not directly alter hormonal cycles. However, rapid weight loss from GLP-1 therapy can sometimes influence cycle regularity due to changes in body composition and metabolic hormones. This typically normalizes over time and is separate from any birth control effect.
How does the PlexusDx Precision Peptide Genetic Test help with contraceptive planning?
The $99 Precision Peptide Genetic Test examines genetic variants in peptide pathways (including GLP1R and MC4R) that influence your weight-loss response and metabolic profile. Understanding your genetic predispositions allows PlexusDx providers to personalize your GLP-1 regimen while monitoring reproductive health more precisely.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
How to Increase My GLP-1: A Comprehensive Guide to Boosting This Essential Hormone
Is 1 mg Semaglutide Enough? A Comprehensive Exploration